Roche (RHHBY)(RHHBF)(RHHVF) said its experimental eye drug vamikibart helped patients maintain improvements in vision for a full year in two late-stage clinical trials, potentially offering an ...
Merck ( MRK) said its experimental eye drug remigromig improved vision in patients with a diabetes-related eye disease, ...
The Daily Mail ventured out to test some of the most viral and out-of-the-box wedding treatments to see whether the ...
Kenneth C. Fan, MD, MBA, shared 4-year REMAIN data showing durable vision gains with MCO-010 in retinitis pigmentosa.
A vote taken by the sound of applause rang out during an early morning session at (AAO) 2026 annual meeting, where 2 experts discussed the pros and cons of using complement inhibitors to treat ...
A case has been published where an internal evaluation AI at OpenAI, unable to find the files required for grading, attempted ...
Kelly Osbourne revealed she gained 28 pounds in six months after photos from the BRIT Awards sparked widespread concern about ...
Roche says vamikibart gains lasted through week 52 in two UME trials as the FDA reviews an application for a decision by July ...
Administering Keytruda via subcutaneous injection instead of an intravenous drip.In September 2026, such a drug was approved.
Roche ( RHHBY ,RO.SW,ROG.SW) announced positive one-year results from its Phase III MEERKAT and SANDCAT studies evaluating investigational therapy vamikibart in adults with uveitic macular edema (UME) ...
Opinion
19hOpinion
Capital punishment is surging in the US – but after Christa Pike’s botched execution, what is its future?
Trump has used the full might of the presidency to supercharge executions, but an avalanche of mishaps has put the system’s flaws in the spotlight ...
Researchers in Dublin report that the enzyme autotaxin and its lipid product lysophosphatidic acid drive fibrosis in lamina ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results